Positivity Rate for Opioids Added to DOT Drug Testing Panel Notably Higher than Traditional Opiates

Written By ESR News Blog Editor Thomas Ahearn Data from the Quest Diagnostics Drug Testing Index™ shows that the positivity rate for four opioids recently added to the U.S. Department of Transportation (DOT) drug test program was notably higher than the rate observed among more traditional opiates, according to a blog from Quest Diagnostics.

Continue reading "Positivity Rate for Opioids Added to DOT Drug Testing Panel Notably Higher than Traditional Opiates"

Analysis of Workforce Drug Testing Results Finds Positivity Rate at Highest Level in a Decade

Written By ESR News Blog Editor Thomas Ahearn Drug use by the U.S. workforce remained at its highest level in more than a decade as the positivity rate for drug tests was 4.2 percent in 2017, the same as in 2016 and the highest since 2004, according to analysis of more than 10 million drug …

Continue reading "Analysis of Workforce Drug Testing Results Finds Positivity Rate at Highest Level in a Decade"

Opioid Crisis in America Will Lead to More Advanced Drug Testing for Opiates by Employers in 2018

Written By ESR News Blog Editor Thomas Ahearn On October 26, 2017, U.S. President Donald Trump officially declared “the opioid crisis a national public health emergency under federal law” and directed executive agencies “to fight the opioid crisis” during a speech at the White House. The growing awareness of an opioid crisis in America by employers …

Continue reading "Opioid Crisis in America Will Lead to More Advanced Drug Testing for Opiates by Employers in 2018"

DOT Issues Final Rule to Add Semi-Synthetic Opioids to Drug Testing Panel to Combat Opioid Epidemic

Written By ESR News Blog Editor Thomas Ahearn The U.S. Department of Transportation (DOT) has issued a final rule in the Federal Register that adds four semi-synthetic opioids – hydrocodone, oxycodone, hydromorphone, and oxymorphone – to its drug testing panel for DOT regulated industries, adds methylenedioxyamphetamine (MDA) as an initial test analyte, and removes the testing …

Continue reading "DOT Issues Final Rule to Add Semi-Synthetic Opioids to Drug Testing Panel to Combat Opioid Epidemic"

Drug Testing for Opioids Expected to Increase after President Trump Declares Opioid Crisis a National Public Health Emergency

Written By ESR News Blog Editor Thomas Ahearn On October 26, 2017, President Donald Trump officially declared “the opioid crisis a national public health emergency under federal law” and directed “all executive agencies to use every appropriate emergency authority to fight the opioid crisis” during remarks in the East Room of the White House.

Continue reading "Drug Testing for Opioids Expected to Increase after President Trump Declares Opioid Crisis a National Public Health Emergency"

Employers Need to Use Proper Drug Testing Panels to Fight Opioid Epidemic in Workplace

Written By ESR News Blog Editor Thomas Ahearn Even with the dramatic rise in the use of opioids – which can include the illegal drug heroin and legally prescribed pain relievers such as OxyContin® and Vicodin® – some employers hoping to avoid hiring opioid-addicted workers through drug testing may not know the best type of drug …

Continue reading "Employers Need to Use Proper Drug Testing Panels to Fight Opioid Epidemic in Workplace"